Safety and Efficacy of Lidocaine Versus Ketamine Infusion for Resistant Orofacial Pain
ConditionOrofacial Pain
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssiut University
About this trial
A prospective, randomized, double-blind clinical trial comparing the safety and efficacy of intravenous lidocaine, ketamine, and their combination as treatment options for patients suffering from treatment-resistant orofacial pain. The study measures pain reduction primarily using the Visual Analog Scale and evaluates safety and tolerability over a follow-up period of 6 months.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Lidocaine Intravenous Infusion
- Ketamine intravenous infusion
- Combined lidocaine and ketamine intravenous infusion
Treatment groups
105 Participants
are divided into 3 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov